In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: Implications for dosage regimens

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1403-1405

  Aguilar, L ^a   Martin M ^b   Balcabao, I P ^b   Gomez Lus M L ^b   Dal Re R ^a   Prieto, J ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b SCHOOL OF MEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CLAVULANIC ACID; NITROCEFIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MIXTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031006107     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1403     Document Type: Article

References (11)

1. Adam, D., I. De Visser, and P. Koeppe. 1982. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob. Agents Chemother. 22:353-357.
2. Craig, W. A., and S. Gudmundsson. 1986. Postantibiotic effect, p. 403-423. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore, Md.
3. Fraschini, F., F. Scaglione, M. Falchi, S. Dugnani, M. Mezzetti, F. Cicchetti, G. Alfano, and G. P. Pintucci. 1990. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J. Chemother. 2:171-177.
4. Gillissen, G., and G. Hasse. 1987. L'acid clavulanique. Son effect sur le staphylocoque dore outre l'effect inhibiteur sur les betalactamases. Pathol. Biol. Paris 35:503-506.
5. Hunter, P. A., K. Coleman, J. Fisher, and D. Taylor. 1980, In vitro synergistic properties of clavulanic acid with ampicillin, amoxicillin and ticarcillin. J. Antimicrob. Chemother. 6:455-470.
6. McDonald, P. J., W. A. Craig, and C. M. Kunin. 1977. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J. Infect. Dis. 135:217-223.
7. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. O'Callagham, C., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
9. Odenholt-Tornqvist, I., E. Löwdin, and O. Cars. 1991. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
10. Thorburn, C. E., and S. J. Molesworth. 1992. The post β-lactamase inhibitor effect (PLIE): a novel aspect of the activity of clavulanic acid in antibacterial tests, abstr. 540, p. 201. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
11. Vogelmann, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158: 831-847.